Clearstead Trust LLC Sells 125 Shares of Oracle Co. (NYSE:ORCL)

Clearstead Trust LLC trimmed its position in Oracle Co. (NYSE:ORCL) by 31.8% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 268 shares of the enterprise software provider’s stock after selling 125 shares during the period. Clearstead Trust LLC’s holdings in Oracle were worth $28,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of ORCL. Orion Capital Management LLC acquired a new stake in Oracle during the 3rd quarter valued at approximately $25,000. Ritter Daniher Financial Advisory LLC DE lifted its holdings in Oracle by 298.4% in the third quarter. Ritter Daniher Financial Advisory LLC DE now owns 243 shares of the enterprise software provider’s stock valued at $26,000 after buying an additional 182 shares during the period. Spartan Planning & Wealth Management bought a new stake in Oracle during the third quarter valued at $27,000. Cornerstone Planning Group LLC grew its holdings in Oracle by 1,268.0% during the 3rd quarter. Cornerstone Planning Group LLC now owns 342 shares of the enterprise software provider’s stock worth $36,000 after acquiring an additional 317 shares during the period. Finally, BOK Financial Private Wealth Inc. raised its position in shares of Oracle by 139.4% in the 4th quarter. BOK Financial Private Wealth Inc. now owns 371 shares of the enterprise software provider’s stock worth $39,000 after acquiring an additional 216 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.

Oracle Stock Performance

ORCL stock traded up $0.84 during midday trading on Friday, hitting $115.80. The company’s stock had a trading volume of 4,484,976 shares, compared to its average volume of 6,128,065. The stock has a market cap of $318.28 billion, a price-to-earnings ratio of 30.55, a PEG ratio of 2.32 and a beta of 1.03. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 13.34. The stock’s 50-day moving average price is $119.91 and its 200 day moving average price is $113.38. Oracle Co. has a 1 year low of $94.41 and a 1 year high of $132.77.

Oracle (NYSE:ORCL) last issued its quarterly earnings results on Monday, March 11th. The enterprise software provider reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.04. The company had revenue of $13.28 billion for the quarter, compared to the consensus estimate of $13.29 billion. Oracle had a net margin of 20.27% and a return on equity of 336.11%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.96 EPS. On average, equities analysts forecast that Oracle Co. will post 4.44 EPS for the current year.

Oracle Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Wednesday, April 10th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.38%. The ex-dividend date was Tuesday, April 9th. Oracle’s payout ratio is 42.22%.

Insiders Place Their Bets

In other Oracle news, Director George H. Conrades sold 25,000 shares of Oracle stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total transaction of $2,903,250.00. Following the transaction, the director now directly owns 17,836 shares of the company’s stock, valued at $2,071,294.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Safra Catz sold 790,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $126.54, for a total transaction of $99,966,600.00. Following the transaction, the chief executive officer now directly owns 1,118,592 shares of the company’s stock, valued at $141,546,631.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director George H. Conrades sold 25,000 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total transaction of $2,903,250.00. Following the transaction, the director now directly owns 17,836 shares in the company, valued at $2,071,294.68. The disclosure for this sale can be found here. Corporate insiders own 42.80% of the company’s stock.

Wall Street Analyst Weigh In

ORCL has been the topic of several research analyst reports. The Goldman Sachs Group upped their target price on Oracle from $115.00 to $130.00 and gave the company a “neutral” rating in a research report on Wednesday, March 13th. Oppenheimer assumed coverage on shares of Oracle in a research note on Thursday, April 18th. They set a “market perform” rating on the stock. KeyCorp assumed coverage on shares of Oracle in a report on Thursday, March 21st. They set an “overweight” rating and a $150.00 price objective on the stock. StockNews.com lowered Oracle from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, HSBC upped their price target on Oracle from $144.00 to $155.00 and gave the stock a “buy” rating in a research note on Wednesday, March 13th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $130.76.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.